Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Kindstar Globalgene Technology, Inc. ( (HK:9960) ) has provided an announcement.
Kindstar Globalgene Technology, Inc. has convened its 2026 annual general meeting as a virtual event on 5 June 2026 to review the audited financial statements for the year ended 31 December 2025 and to decide on a series of key governance matters. Shareholders will vote on the re-election of several executive, non-executive and independent non-executive directors, the authorization of the board to set directors’ pay, and the re-appointment of Ernst & Young as auditor.
The meeting will also seek shareholder approval for general mandates allowing the board to repurchase up to 10% of the company’s issued shares and to allot, issue or transfer additional shares, including any treasury shares, subject to Hong Kong listing rules. These mandates, if granted, would enhance the company’s capital management flexibility, support potential fundraising or equity incentives and may influence share liquidity and capital structure over the coming year.
More about Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. is a Cayman Islands–incorporated company listed in Hong Kong, operating in the medical and biotechnology testing sector. The company focuses on specialized diagnostic services and leverages its market position through a listed share structure that enables capital-raising and corporate flexibility.
Average Trading Volume: 430,201
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.21B
For a thorough assessment of 9960 stock, go to TipRanks’ Stock Analysis page.